레이크쇼어 바이오파마(LSBCF)는 NYSE에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.07 (+0.00%), 시가총액 $2.06M, 52주 범위 $0.03 ~ $1.38.
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of…
레이크쇼어 바이오파마의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
레이크쇼어 바이오파마의 현재 주가는 $0.07 (+0.00%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
레이크쇼어 바이오파마의 시가총액은 약 $2.06M입니다.
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer.